Urate Dynamics After CHOP Therapy in Patients With Malignant Lymphoma.

Gout and Nucleic Acid Metabolism
doi 10.6032/gnam1999.27.1_11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Gout and Nucleic Acid Metabolism

Related search

Advances in Targeted Therapy for Malignant Lymphoma

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

Granisetron Plus Aprepitant Versus Granisetron in Preventing Nausea and Vomiting During CHOP or R-Chop Regimen in Malignant Lymphoma: A Retrospective Study

Journal of Pharmaceutical Health Care and Sciences
2019English

Oral Lichen Planus Developing After PD-1 Inhibitor Therapy in Two Patients With Malignant Melanoma

Journal of Clinical and Investigative Dermatology
2019English

Dyslipidemia, Alcohol Consumption and Obesity Are the Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy

Arthritis Care and Research
Rheumatology
2018English

Two Cases of Pneumocystis Jiroveci Pneumonia With Non-Hodgkin's Lymphoma After CHOP-Based Chemotherapy Containing Rituximab

Journal of clinical and experimental hematopathology : JCEH
Medicine
2010English

Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Malignant Lymphoma in Leprosy Patients of Our Autopsy Series

Japanese journal of leprosy
1989English

Retreatment With Nivolumab in Patients With R/R Classical Hodgkin Lymphoma After Discontinuation of the Therapy With Immune Checkpoint Inhibitors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

R-Chop With or Without Bevacizumab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma: Final MAIN Study Outcomes

Haematologica
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy